Leave your contact details and we will contact you
According to the RNC Pharma® database “Audit of Retail Sales of Medicinal Products in Russia (total sell-out)”, in Q1–Q3 2025, Russian consumers purchased 22.7 million packages of nasal and throat rinsing products based on saline solutions, including sea water1, spending a total of RUB 10.8 billion (in retail prices including VAT). Compared with the same period in 2024, sales in this category grew by 10.8% in value and 4.3% in volume. In 2024 vs. 2023, value growth was significantly higher (+17%), while volume growth was comparable (+4.2%).
The role of online sales in this category continues to expand: in Q1–Q3 2025, value dynamics in the e-commerce channel exceeded +46%, which is five times higher than the growth rate in traditional retail outlets. The total value share of marketplaces reached 5%, compared to 3.8% a year earlier. The largest online platforms — Ozon and Yandex Market — accounted for a combined 61% of e-commerce turnover in this category. By contrast, the FMCG channel’s share declined and currently does not exceed 0.2%.
During the reporting period, 36 companies were active in the retail market, offering 40 brands and a combined 223 SKUs. Remarkably, the top 10 brands accounted for 95.7% of total value sales.
The largest consumer spending was directed toward Aqualor (Nizhpharm), which held a 37.7% market share in value terms. Aqua Maris (Jadran Galenski Laboratorij, Croatia) retained the second position with 28.2%, while LinAqua (Groteks, Russia) ranked third, generating 11.7% of total sales. The Dolphin device and nasal rinsing solution (Zentiva) ranked fourth, showing +19% growth in value and +4% in volume versus Q1–Q3 2024.
Among the top-performing products, Rankof (Profit Pharm) demonstrated the highest growth — sales nearly tripled in value and rose 2.3 times in volume. Other notable gainers included Nosifit (Artelar, +167%) and Aquarosa (KS Trade, +103%).
For the second consecutive year, demand for LinAqua (Groteks) continued to decline — sales fell by 26% in value and 35% in volume year-on-year. The drop affected the entire product line (around 16 SKUs), likely due to contract manufacturing of several SKUs under other private labels such as Akvazivin and Nosifit, which are also produced by the company. Within the Top 10, Aquanazal (Altayvitamins) also recorded a decline of –12% in value and –24% in volume.
Outside the top 10, one of the strongest performers was Aspecton nasal spray (Krevel), whose sales increased 12-fold in value and 16-fold in volume year-on-year.
Top 10 Brands of nasal and throat rinsing products based on saline solutions including sea water by retail sales value in Russia, including marketplaces and FMCG channel, Q1–Q3 2025
| № | Brand | Company | Share in Q1-Q3 2025, %, RUB | Dynamics vs. Q1–Q3 2024, %, RUB |
| 1 | Aqualor | Nizhpharm | 37.7 | 14 |
| 2 | Aqua Maris | Jadran Galenski Laboratorij | 28.2 | 13 |
| 3 | LinAqua | Groteks | 11.7 | -26 |
| 4 | Dolphin | Zentiva | 9.3 | 19 |
| 5 | Nosifit | Artelar | 2.3 | 167 |
| 6 | Aquarosa | KS Trade | 1.5 | 103 |
| 7 | Akvazivin | Erkapharm | 1.5 | 13 |
| 8 | Aquanazal | Altayvitamins | 1.4 | -12 |
| 9 | Rankof | Profit Pharm | 1.2 | 188 |
| 10 | Quixx | Menarini | 0.8 | 10 |
| Source: RNC Pharma®, Audit of Retail Sales of Medicinal Products in Russia (total sell-out) | ||||
[1] The analysis covered all products in the form of aerosols, sprays, drops, lyophilizates, and powders for solution preparation containing sea water and sodium chloride, as well as specialized devices designed for nasal and throat rinsing and irrigation, registered as medicinal products, medical devices, or cosmetic products.
Leave your contact details and we will contact you